Trial intelligence / Profile preview

BariVaDia: Endothelial Function in Obese Patients With and Without Type-2 Diabetes After Bariatric Surgery

NCT03636243Completed

Sponsor
CHU Nîmes
Start
Oct 2019
Primary completion
Aug 2025
Countries
1
01

Overview

Trial (2 arms), sponsored by CHU Nîmes. Primary endpoint: Reactive Hyperemia Index at Month 3. Started Oct 2019; status: completed.

Beyond the preview

Go deeper on NCT03636243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03636243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call